The Technical Analyst
Select Language :
Zentalis Pharmaceuticals [ZNTL]

Exchange: NasdaqGS Sector: Healthcare Industry: Biotechnology

Zentalis Pharmaceuticals Price, Forecast, Insider, Ratings, Fundamentals & Signals

Current Signal: SELL (auto-tracking)

Zentalis Pharmaceuticals is listed at the NASDAQ Exchange

14.08% $23.42

Last updated: 16 May 2022 @ 11:40 am


FUNDAMENTALS
MarketCap: 1 092.07 mill
EPS: -3.72
P/E: 0.000
Earnings Date: Aug 10, 2022
SharesOutstanding: 46.63 mill
Avg Daily Volume: 0.687 mill
RATING 2022-05-13
B
Neutral
RATINGDETAILS
Rating CashFlow: Strong Buy
Return On Equity: Sell
Return On Asset: Sell
DE: Neutral
P/E: Strong Sell
Price To Book: Strong Buy
QUARTER GROWTHS
4/201/212/213/214/211/22
Revenuen/an/an/an/an/an/a
Gr.Profitn/an/an/an/an/an/a
Ebit
Asset
Debt
DISCOUNTED CASH FLOW VALUE
$25.54
(9.07%) $2.12
Date: 2022-05-16
True Range Average
+/- $2.90
( +/- 14.12%)
Range: 17.63 - 23.43
ATR Model: 14 days

Insider Trading

Date Person Action Amount type
2022-04-11 Bunker Kevin D. Sell 100 Common Stock
2022-04-11 Bunker Kevin D. Sell 300 Common Stock
2022-04-11 Bunker Kevin D. Sell 4 600 Common Stock
2022-04-05 Gallagher Cam Sell 100 Common Stock
2022-04-05 Gallagher Cam Sell 2 196 Common Stock
INSIDER POWER
-43.75
Last 100 transactions
Buy: 200 338 | Sell: 531 799

Forecast: 13:19 - $23.31

Live Trading Signals (every 1 min)

Forecast 1: 11:49 - $23.33
Forecast 2: 12:39 - $22.66
Forecast 3: 13:19 - $23.31
SCORE
-10.00
Sell
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Indicator Signals
RSI 21
SMA
Trend
Trend 2
Trend 3
MACD
Volume Signals
Price $23.42 (14.08% )
Volume 1.741 mill
Avg. Vol. 0.687 mill
% of Avg. Vol 253.49 %
Signal 1:
Signal 2:

Today

Intraday chart data with high, low, open and close for Zentalis Pharmaceuticals Inc

Last 12 Months

Last 12 months chart data with high, low, open and close for Zentalis Pharmaceuticals Inc

RSI

Intraday RSI14 chart for Zentalis Pharmaceuticals Inc

Last 10 Buy & Sell Signals For ZNTL

275 Signals | Accuracy: 26.55% | Accuracy Buy: 28.47% | Accuracy Sell: 24.64%

Avg return buy: -0.07 % | Avg return sell: -0.04 %

$1 invested is now $0.91 or -9.36% since 20-04-22

Date Signal @ Closed %
May 16 - 10:37sell$25.00$25.38 @ May 16 - 10:391.52%
May 16 - 09:58buy$22.22$21.92 @ May 16 - 10:02-1.35%
May 16 - 09:54sell$21.92$22.22 @ May 16 - 09:581.37%
May 16 - 09:36buy$21.48$21.95 @ May 16 - 09:522.19%
May 13 - 15:35sell$21.29$21.31 @ May 16 - 09:350.09%
May 13 - 15:23buy$21.40$21.30 @ May 13 - 15:34-0.49%
May 13 - 15:20sell$21.29$21.40 @ May 13 - 15:220.52%
May 13 - 15:18buy$21.33$21.29 @ May 13 - 15:20-0.19%
May 13 - 15:16sell$21.30$21.33 @ May 13 - 15:180.14%
May 13 - 14:52buy$21.12$21.31 @ May 13 - 15:150.90%
The Live Chart for Zentalis Pharmaceuticals Inc
Profile picture for
            Zentalis Pharmaceuticals Inc

ZNTL

Zentalis Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops small molecule therapeutics for the treatment of various cancers in the United States. Its lead product candidate is the ZN-c5, an oral selective estrogen receptor degrader that is in a Phase I/II clinical trial for the treatment of advanced or metastatic breast cancer. The company also develops ZN-c3, an inhibitor of WEE1, a protein tyrosine kinase, which is in Phase I/II clinical trial for the treatment of advanced solid tumors; ZN-d5, a selective inhibitor of B-cell lymphoma 2 for the treatment of hematological malignancies; and ZN-e4, an irreversible inhibitor of mutant epidermal growth factor receptor that is in Phase I/II clinical trial for the treatment of advanced non-small cell lung cancer. Zentalis Pharmaceuticals, Inc. was founded in 2014 and is based in New York, New York.

Last 10 Buy Signals
Date Signal @
VTRSMay 16 - 11:38$11.11
USIGMay 16 - 11:38$51.87
SLMMay 16 - 11:38$16.73
PNFPPMay 16 - 11:38$25.04
PCTMay 16 - 11:38$8.58
NMRKMay 16 - 11:38$11.28
NCNAMay 16 - 11:38GBP0.592
KURAMay 16 - 11:38$11.69
KFRCMay 16 - 11:37$70.52
IUSBMay 16 - 11:38$47.54

Stock Peers

Company Price Change
ZNTL23.4214.08%
AXNX48.352.24%
CORT19.332.06%
GBT27.778.35%
HCAT15.10-6.39%
IRTC138.33-0.51%
MGLN94.990.00%
OM25.904.18%
OPK3.01-0.66%
SEER8.48-2.53%
VCEL28.28-0.09%

Latest Press Releases

Latest News

Disclaimer:

"JimStromberg.com" is a research service that provides financial data and technical analysis of publicly traded stocks. All users should speak with their financial advisor before buying or selling any securities. Users should not base their investment decision upon "JimStromberg.com". By using the site you agree and are held liable for your own investment decisions and agree to Terms of Use and Privacy Policy. Please read the full disclaimer here.